Clinical characteristics of post-transplant lymphoproliferative disorders
- 31 July 1994
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (1) , 14-24
- https://doi.org/10.1016/0002-9343(94)90043-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- COMPLETE REMISSION AND POSSIBLE IMMUNE TOLERANCE AFTER MULTIDRUG COMBINATION CHEMOTHERAPY FOR CYCLOSPORINE-RELATED LYMPHOMA IN A RENAL TRANSPLANT RECIPIENT WITH ACUTE PANCREATITISTransplantation, 1991
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- EPSTEIN-BARR VIRUS—DETERMINED CLONALITY IN POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASETransplantation, 1990
- INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONETransplantation, 1989
- Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantationThe American Journal of Medicine, 1989
- Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma GlobulinNew England Journal of Medicine, 1988
- T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus InfectionsNew England Journal of Medicine, 1988
- Ifosfamide and etoposide as salvage therapy for non‐Hodgkin's lymphomaScandinavian Journal of Haematology, 1986
- EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B CELL LYMPHOPROLIFERATIONTransplantation, 1985
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976